Última actualización 29 de agosto de 2026
Key finding
After 3 months, patients in the intervention group showed significant (P <.05) improvement in postprandial plasma glucose level.
This study evaluated the effectiveness of a mobile health system in improving glycemic control among older Chinese patients with type 2 diabetes mellitus (T2DM). Results indicated significant improvements in postprandial plasma glucose and glycated hemoglobin levels.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Extended (5–20+ y)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the effectiveness of a mobile health system in improving glycemic control among older Chinese patients with type 2 diabetes mellitus (T2DM). Results indicated significant improvements in postprandial plasma glucose and glycated hemoglobin levels.
Improving glycemic control is crucial for older adults with T2DM to reduce the risk of complications. This study highlights the potential of mobile health technologies to support diabetes management, suggesting that such interventions could be integrated into routine care for older patients to enhance their health outcomes.
Unclear effectiveness due to limited evidence pairs. Potential selection bias in participant recruitment. Results may not be generalizable to younger populations.
Published in
Publication details and source links for this paper.
Gunther E, Katharina S, Peter R, et al. Mobile Phone–Based Telemedicine Apps Help Improve Glycemic Control in Older Chinese Patients with T2DM. JMIR mHealth and uHealth. 2019;7(1):e10664. doi:10.2196/10664
Postprandial plasma glucose decreased by 2.48 mmol/L in the intervention group (P = 0.004).
Glycated hemoglobin (HbA1c) levels decreased by 1.07% in the intervention group (P = 0.045).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to mHealth diabetes support intervention and Glucose iAUC (OGTT), HbA1c.
This study contributes evidence to
Primary intervention
mHealth diabetes support intervention
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
2
Evidence pairs
817
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Relación de evidencia
Evidencia relacionada
Relación de evidencia
Guardar evidencia
Tema de evidencia
Guardar evidencia
Core evidence
The primary outcomes reported in this study.
mHealth diabetes support intervention → Glucose iAUC (OGTT)
mHealth diabetes support intervention → Glucose iAUC (OGTT)
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on mHealth Diabetes Support Interventions and HbA1c, mHealth Diabetes Support Interventions and Postprandial and OGTT Glucose.
This study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Behavioral & Lifestyle
Curated evidence collections and hubs this study is part of.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies on mHealth Diabetes Support Interventions
Contributes to mHealth Diabetes Support Interventions evidence base.
All studies measuring Postprandial and OGTT Glucose
Measures Postprandial and OGTT Glucose as a key outcome.
Jump to pre-filtered views in Evidence Explorer.
4 results
1 results
4 results
4 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
mHealth Diabetes Support Interventions may improve HbA1c.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on 6 supporting studies with consistent results and a positive effect signal.
Limitations
mHealth Diabetes Support Interventions appears to improve Postprandial and OGTT Glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Glucose iAUC (OGTT)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Centrada en la evidencia, no en la publicidad.
Tus datos siempre están protegidos.
Se agregan nuevos estudios todos los días.
